Drug analysis of a fatal case of bloodstream infection combined with urinary tract infection due to echinocandin-resistant Candida glabrata
Abstract
When a urinary tract infection (UTI) progresses to a bloodstream infection (BSI), the choice of therapeutic drugs should consider their effectiveness against both BSI and UTI. C. glabrata exhibits strong resistance to antifungal drugs, making the treatment of BSI combined with UTI caused by this pathogen challenging. We report a fatal case of BSI combined with UTI caused by echinocandin-resistant C. glabrata in a 68-year-old female patient. The patient was treated with fluconazole, caspofungin, voriconazole, amphotericin B, and 5-flucytosine throughout the treatment process, but the infection was not controlled in the end. We analyzed the shortcomings in the medication process to provide some references for physicians in clinical treatment.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.